These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22935368)

  • 21. Methotrexate-loaded biodegradable polymeric micelles: preparation, physicochemical properties and in vitro drug release.
    Zhang Y; Jin T; Zhuo RX
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):104-9. PubMed ID: 16039836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
    Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
    Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling of diffusion controlled drug delivery.
    Siepmann J; Siepmann F
    J Control Release; 2012 Jul; 161(2):351-62. PubMed ID: 22019555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermoresponsive nanostructured polycarbonate block copolymers as biodegradable therapeutic delivery carriers.
    Kim SH; Tan JP; Fukushima K; Nederberg F; Yang YY; Waymouth RM; Hedrick JL
    Biomaterials; 2011 Aug; 32(23):5505-14. PubMed ID: 21529935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of polymeric nanostructure shape on drug delivery.
    Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilising atomic force microscopy for the characterisation of nanoscale drug delivery systems.
    Sitterberg J; Ozcetin A; Ehrhardt C; Bakowsky U
    Eur J Pharm Biopharm; 2010 Jan; 74(1):2-13. PubMed ID: 19755155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs.
    Zolnik BS; Sadrieh N
    Adv Drug Deliv Rev; 2009 Jun; 61(6):422-7. PubMed ID: 19389437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH-sensitive supramolecular polypeptide-based micelles and reverse micelles mediated by hydrogen-bonding interactions or host-guest chemistry: characterization and in vitro controlled drug release.
    Chen Y; Dong CM
    J Phys Chem B; 2010 Jun; 114(22):7461-8. PubMed ID: 20469900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabrication of nanoparticles within polymeric pores for controlled release of drug.
    Asif M; Arayne MS; Sultana N; Hussain F
    Pak J Pharm Sci; 2006 Jan; 19(1):73-84. PubMed ID: 16632458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled loading and release of a model drug from polypeptide multilayer nanofilms.
    Zhong Y; Whittington CF; Zhang L; Haynie DT
    Nanomedicine; 2007 Jun; 3(2):154-60. PubMed ID: 17572357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.
    Kipp JE
    Int J Pharm; 2004 Oct; 284(1-2):109-22. PubMed ID: 15454302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of acetazolamide composite microparticles by supercritical anti-solvent techniques.
    Duarte AR; Roy C; Vega-González A; Duarte CM; Subra-Paternault P
    Int J Pharm; 2007 Mar; 332(1-2):132-9. PubMed ID: 17055198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scanning probe microscopy in the field of drug delivery.
    Turner YT; Roberts CJ; Davies MC
    Adv Drug Deliv Rev; 2007 Dec; 59(14):1453-73. PubMed ID: 17920719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.